Abstract
Clinical isolates of the Bacteroides melaninogenicus and Bacteroides fragilis groups were tested for in vitro and in vivo susceptibility to penicillin, clindamycin, and metronidazole, used singly or in combination with gentamicin. The in vitro tests consisted of determinations of minimal inhibitory concentrations (MICs) carried out with or without constant amounts of gentamicin. When used alone, gentamicin had negligible effects on the bacteria but significantly reduced the MICs of penicillin, clindamycin, and metronidazole against 11, 10, and 3, of the 15 strains of the B. melaninogenicus group, respectively. The 15 strains of the B. fragilis group were all beta-lactamase producers and were highly resistant to penicillin or the combination of penicillin and gentamicin. However, gentamicin reduced the MICs of clindamycin and metronidazole against 1 and 7 strains of this group, respectively. The in vivo tests were carried out in mice and consisted of measurements of the effects of the antimicrobial agents on the sizes and bacterial content of abscesses induced by subcutaneous injection of bacterial suspensions. The results of the in vivo tests were generally consistent with those obtained in vitro with strains of the B. melaninogenicus group. Synergism between gentamicin and penicillin, clindamycin, or metronidazole was shown in 13, 10, and 3 strains of this group, respectively. In vivo synergism was not clearly demonstrated with the strains of the B. fragilis group, possibly because clindamycin and metronidazole used alone were highly efficacious. We suggest that the synergistic effect of gentamicin is due to its increased transport into the bacterial cell in the presence of penicillin and, possibly, other antimicrobial agents. The newly recognized in vitro and in vivo synergism between penicillin and other antimicrobial agents and an aminoglycoside in B. melaninogenicus may have clinical implications that deserve to be investigated.
Full text
PDF






Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brook I. Anaerobic bacteria in pediatric respiratory infection: progress in diagnosis and treatment. South Med J. 1981 Jun;74(6):719–726. doi: 10.1097/00007611-198106000-00023. [DOI] [PubMed] [Google Scholar]
- Brook I., Finegold S. M. Aerobic and anaerobic bacteriology of cutaneous abscesses in children. Pediatrics. 1981 Jun;67(6):891–895. [PubMed] [Google Scholar]
- Bryan L. E., Kowand S. K., Van Den Elzen H. M. Mechanism of aminoglycoside antibiotic resistance in anaerobic bacteria: Clostridium perfringens and Bacteroides fragilis. Antimicrob Agents Chemother. 1979 Jan;15(1):7–13. doi: 10.1128/aac.15.1.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Busch D. F., Sutter V. L., Finegold S. M. Activity of combinations of antimicrobial agents against Bacteroides fragilis. J Infect Dis. 1976 Mar;133(3):321–328. doi: 10.1093/infdis/133.3.321. [DOI] [PubMed] [Google Scholar]
- Fass R. J., Rotilie C. A., Prior R. B. Interaction of clindamycin and gentamicin in vitro. Antimicrob Agents Chemother. 1974 Nov;6(5):582–587. doi: 10.1128/aac.6.5.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gorbach S. L., Bartlett J. G. Anaerobic infections. 1. N Engl J Med. 1974 May 23;290(21):1177–1184. doi: 10.1056/NEJM197405232902106. [DOI] [PubMed] [Google Scholar]
- Kasper D. L., Onderdonk A. B., Polk B. F., Bartlett J. G. Surface antigens as virulence factors in infection with Bacteroides fragilis. Rev Infect Dis. 1979 Mar-Apr;1(2):278–290. doi: 10.1093/clinids/1.2.278. [DOI] [PubMed] [Google Scholar]
- Klastersky J., Husson M. Bactericidal activity of the combinations of gentamicin with clindamycin or chloramphenicol against species of Escherichia coli and Bacteroides fragilis. Antimicrob Agents Chemother. 1977 Aug;12(2):135–138. doi: 10.1128/aac.12.2.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Laufer J., Mignon H., Videau D. L'association métronidazole-spiramycine. Concentrations et synergie in situ comparées aux CMI de la flore buccale. Rev Stomatol Chir Maxillofac. 1974 Jul-Aug;74(5):387–392. [PubMed] [Google Scholar]
- Leigh D. A. Letter: Bacteroides infections. Lancet. 1973 Nov 10;2(7837):1081–1082. doi: 10.1016/s0140-6736(73)92680-9. [DOI] [PubMed] [Google Scholar]
- O'Callaghan C. H., Morris A., Kirby S. M., Shingler A. H. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother. 1972 Apr;1(4):283–288. doi: 10.1128/aac.1.4.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Okubadejo O. A., Allen J. Combined activity of clindamycin and gentamicin on Bacteroides fragilis and other bacteria. J Antimicrob Chemother. 1975 Dec;1(4):403–409. doi: 10.1093/jac/1.4.403. [DOI] [PubMed] [Google Scholar]
- Rahal J. J., Jr Antibiotic combinations: the clinical relevance of synergy and antagonism. Medicine (Baltimore) 1978 Mar;57(2):179–195. [PubMed] [Google Scholar]
- Ralph E. D., Amatnieks Y. E. Potentially synergistic antimicrobial combinations with metronidazole against Bacteroides fragilis. Antimicrob Agents Chemother. 1980 Mar;17(3):379–382. doi: 10.1128/aac.17.3.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thadepalli H., White D. W., Bach V. T. Antimicrobial activity and synergism of cefuroxime on anaerobic bacteria. Chemotherapy. 1981;27(4):252–258. doi: 10.1159/000237988. [DOI] [PubMed] [Google Scholar]
- Wheeler L. A., De Meo M., Halula M., George L., Heseltine P. Use of high-pressure liquid chromatography to determine plasma levels of metronidazole and metabolites after intravenous administration. Antimicrob Agents Chemother. 1978 Feb;13(2):205–209. doi: 10.1128/aac.13.2.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Whelan J. P., Hale J. H. Bactericidal activity of metronidazole against Bacteroides fragilis. J Clin Pathol. 1973 Jun;26(6):393–395. doi: 10.1136/jcp.26.6.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
